Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 5571
TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373225BDBM373225(US20260022122, Example 16)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373231BDBM373231(US20260022122, Example 22)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373228BDBM373228(US20260022122, Example 19)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373234BDBM373234(US20260022122, Example 25)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373233BDBM373233(US20260022122, Example 24)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373232BDBM373232(US20260022122, Example 23)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373241BDBM373241(US20260022122, Example 30)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373239BDBM373239(US20260022122, Example 29)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373248BDBM373248(US20260022122, Example 34)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373247BDBM373247(US20260022122, Example 33)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373246BDBM373246(US20260022122, Example 32)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373243BDBM373243(US20260022122, Example 31)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373255BDBM373255(US20260022122, Example 38)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373249BDBM373249(US20260022122, Example 35)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373263BDBM373263(US20260022122, Example 42)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373260BDBM373260(US20260022122, Example 41)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373259BDBM373259(US20260022122, Example 40)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373256BDBM373256(US20260022122, Example 39)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373269BDBM373269(US20260022122, Example 45)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373265BDBM373265(US20260022122, Example 44)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373264BDBM373264(US20260022122, Example 43)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373277BDBM373277(US20260022122, Example 49)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373276BDBM373276(US20260022122, Example 48)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373271BDBM373271(US20260022122, Example 47)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373282BDBM373282(US20260022122, Example 53)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373281BDBM373281(US20260022122, Example 52)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373280BDBM373280(US20260022122, Example 51)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373292BDBM373292(US20260022122, Example 58)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373295BDBM373295(US20260022122, Example 60)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373300BDBM373300(US20260022122, Example 63)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373212BDBM373212(US20260022122, Example 6)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373210BDBM373210(US20260022122, Example 4)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373209BDBM373209(US20260022122, Example 3)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373217BDBM373217(US20260022122, Example 10)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373215BDBM373215(US20260022122, Example 9)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373214BDBM373214(US20260022122, Example 8)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373213BDBM373213(US20260022122, Example 7)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373222BDBM373222(US20260022122, Example 14)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373221BDBM373221(US20260022122, Example 13)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373219BDBM373219(US20260022122, Example 11)
Affinity DataIC50: 50nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373279BDBM373279(US20260022122, Example 50)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373208BDBM373208(US20260022122, Example 2)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373226BDBM373226(US20260022122, Example 17)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373207BDBM373207(US20260022122, Example 1)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373283BDBM373283(US20260022122, Example 54)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373235BDBM373235(US20260022122, Example 26)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373270BDBM373270(US20260022122, Example 46)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373297BDBM373297(US20260022122, Example 62)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373220BDBM373220(US20260022122, Example 12)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

TargetNicotinamide phosphoribosyltransferase(Human)
Checkmate Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 373236BDBM373236(US20260022122, Example 27)
Affinity DataIC50: 75nMAssay Description:To test the effect of the compound prepared in each Example on the substrate decomposition rate (Vmax/min) mediated by NamPT enzyme, IC50 was calcula...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/3/2026
Entry Details
US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: